Latest Breaking News On - Glucose cotransport protein - Page 1 : comparemela.com

Compared to nonusers, patients with type 2 diabetes and acute kidney disease administered SGLT-2is had a significantly lower risk of mortality, major adverse kidney events, and major adverse cardiovascular events.

Researchgate heng chih panKeelung chang gungHeng chih panChang gung research databaseNational kidney foundationUs centers for diseaseDisease controlKeelung chang gung memorial hospitalChang gung researchGlucose cotransport proteinPatients with typeAcute kidneyChronic kidney diseaseDoes typeIncrease your riskAccessed january